Gena Kanas

952 total citations · 1 hit paper
13 papers, 666 citations indexed

About

Gena Kanas is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Gena Kanas has authored 13 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Gena Kanas's work include Cancer Immunotherapy and Biomarkers (3 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Ferroptosis and cancer prognosis (2 papers). Gena Kanas is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Ferroptosis and cancer prognosis (2 papers). Gena Kanas collaborates with scholars based in United States, Germany and United Kingdom. Gena Kanas's co-authors include Fionna Mowat, Wendy Langeberg, Michael A. Choti, Graeme J. Poston, Aliki Taylor, John Primrose, Wenzhen Ge, Jon Arnason, Ruben G.W. Quek and Li Lin and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Haematology and Breast Cancer Research and Treatment.

In The Last Decade

Gena Kanas

13 papers receiving 660 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors

2012 488 citations Aliki Taylor, John Primrose et al. Clinical Epidemiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gena Kanas United States	6	407	318	190	135	89	13	666
M. Luboinski France	9	392 1.0×	451 1.4×	224 1.2×	232 1.7×	87 1.0×	13	857
Seta Shahin United States	8	812 2.0×	186 0.6×	110 0.6×	319 2.4×	145 1.6×	13	948
L. Leong United States	16	648 1.6×	188 0.6×	238 1.3×	241 1.8×	144 1.6×	41	1.0k
A. Viúdez Spain	16	503 1.2×	319 1.0×	196 1.0×	271 2.0×	52 0.6×	53	887
Kian Fong Foo Singapore	13	320 0.8×	129 0.4×	193 1.0×	238 1.8×	78 0.9×	24	712
Nicolas Martin France	14	244 0.6×	107 0.3×	140 0.7×	385 2.9×	30 0.3×	50	711
B. Nelson United States	7	795 2.0×	199 0.6×	167 0.9×	278 2.1×	92 1.0×	12	1.0k
Milan E. J. Pijl Netherlands	10	300 0.7×	373 1.2×	234 1.2×	121 0.9×	17 0.2×	23	836
J Anderson Australia	9	232 0.6×	429 1.3×	173 0.9×	216 1.6×	23 0.3×	19	681

Countries citing papers authored by Gena Kanas

Since Specialization

Citations

This map shows the geographic impact of Gena Kanas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gena Kanas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gena Kanas more than expected).

Fields of papers citing papers by Gena Kanas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gena Kanas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gena Kanas. The network helps show where Gena Kanas may publish in the future.

Co-authorship network of co-authors of Gena Kanas

This figure shows the co-authorship network connecting the top 25 collaborators of Gena Kanas. A scholar is included among the top collaborators of Gena Kanas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gena Kanas. Gena Kanas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Clark, O, Akira Yuasa, Shigeru Sugiyama, et al.. (2024). Treatment Patterns in Metastatic Bladder Cancer in Japan: Results of the CancerMPact ^® Survey 2020. Future Oncology. 20(10). 603–611. 1 indexed citations

2.

Clark, O, et al.. (2023). Physician Reported Treatment Patterns and Outcomes in Metastatic Bladder Cancer in the USA: The CancerMPact ^® Survey 2020. Future Oncology. 20(10). 613–622. 2 indexed citations

3.

Murali, Bhavna, Linda Yang, Song Li, et al.. (2022). Treatment of HR+/HER2− breast cancer in urban mainland China: results from the CancerMPact Survey 2019. Breast Cancer Research and Treatment. 195(3). 441–451. 1 indexed citations

4.

Murali, Bhavna, Song Li, Linda Zhao, et al.. (2021). Treatment patterns in non-small-cell lung cancer in China: Results from the CancerMPact survey 2020. Cancer Treatment and Research Communications. 29. 100462–100462. 6 indexed citations

5.

Moreira, Eloisa De Sá, David S. Robinson, Linda Zhao, et al.. (2021). Patterns of Care and Outcomes for Non-Metastatic Prostate Cancer in the United States: Results of the CancerMPact® Survey 2018. Cancer Management and Research. Volume 13. 9127–9137. 4 indexed citations

6.

Kanas, Gena, et al.. (2021). Epidemiology of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) in the United States and Western Europe: population-level projections for 2020–2025. Leukemia & lymphoma. 63(1). 54–63. 68 indexed citations

7.

Zhao, Linda, et al.. (2020). <p>Treatment of Advanced/Metastatic Melanoma in the United States and Western Europe: Results of the CancerMPact Survey</p>. Cancer Management and Research. Volume 12. 5633–5639. 3 indexed citations

8.

Kanas, Gena, et al.. (2020). Estimate of Multiple Myeloma Patients by Line of Therapy in the USA: Population-Level Projections 2020–2025. Future Oncology. 17(8). 921–930. 6 indexed citations

9.

Robinson, David S., et al.. (2020). Treatment patterns in non-small-cell lung cancer in USA: results of the CancerMPact Survey 2018. Future Oncology. 16(7). 255–262. 6 indexed citations

10.

Taylor, Aliki, John Primrose, Wendy Langeberg, et al.. (2012). Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clinical Epidemiology. 4. 283–283. 488 indexed citations breakdown →

11.

Kanas, Gena, et al.. (2010). Use of electronic medical records in oncology outcomes research. SHILAP Revista de lepidopterología. 1 indexed citations

12.

Yong, Mellissa, W. Marieke Schoonen, Li Lin, et al.. (2010). Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database. British Journal of Haematology. 149(6). 855–864. 77 indexed citations

13.

Kanas, Gena, et al.. (2009). Use of electronic medical records (EMRs) in oncology outcomes research. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact